Search

Your search keyword '"MUMFORD, DOUG"' showing total 7 results
Start Over Author "MUMFORD, DOUG"
7 results on '"MUMFORD, DOUG"'

2. Point-of-Care Capillary Blood Ketone Measurements and the Prediction of Future Ketoacidosis Risk in Type 1 Diabetes

Author

Song, Cimon, primary, Dhaliwal, Sharon, additional, Bapat, Priya, additional, Scarr, Daniel, additional, Bakhsh, Abdulmohsen, additional, Budhram, Dalton, additional, Verhoeff, Natasha J., additional, Weisman, Alanna, additional, Fralick, Michael, additional, Ivers, Noah M., additional, Cherney, David Z.I., additional, Tomlinson, George, additional, Lovblom, Leif Erik, additional, Mumford, Doug, additional, and Perkins, Bruce A., additional

Published
2023
Full Text
View/download PDF

6. PROGNOSTIC IMPLICATIONS OF DIABETIC KETOACIDOSIS ON LONG-TERM MORTALITY AND DIABETES-RELATED COMPLICATIONS

Author

Budhram, Dalton R., Bapat, Priya, Bakhsh, Abdulmohsen, Abuabat, Mohammad I., Verhoeff, Natasha J., Mumford, Doug, Orszag, Andrej, Jain, Akshay, Cherney, David Z.I., Fralick, Michael, Weisman, Alanna, Lovblom, Leif Erik, and Perkins, Bruce A.

Abstract

Diabetic ketoacidosis (DKA) occurring after diabetes diagnosis is often associated with risk factors for other diabetes-related complications. We aimed to determine the prognostic implications of DKA on all-cause mortality and complications in type 1 diabetes (T1D).

Published
2024
Full Text
View/download PDF

7. Insulin Pump Use and Diabetic Ketoacidosis Risk in Type 1 Diabetes: Secular Trends over Four Decades.

Author

Budhram DR, Bapat P, Bakhsh A, Abuabat MI, Verhoeff NJ, Mumford D, Cheema W, Orszag A, Jain A, Cherney DZI, Fralick M, Alamri BN, Weisman A, Lovblom LE, and Perkins BA

Abstract

Introduction: Continuous subcutaneous insulin infusion (CSII) in type 1 diabetes has been regarded as a major diabetic ketoacidosis (DKA) risk factor. We aimed to determine secular trends in risk since CSII implementation in the 1980s. Research Design and Methods: We assessed the relationship between time-varying CSII use and DKA events from 1983 to 2017 and by each decade in the 1441 Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study participants using crude and adjusted Cox proportional hazards models. Results: Time-varying CSII exposure was associated with significantly higher DKA risk in the 1980s (adjusted hazard ratio [HR] 5.81; 95% confidence interval [CI] 3.28-10.29; P < 0.001), but in the 2010s, this risk was not significantly elevated (adjusted HR 1.24; 95% CI 0.73-2.12; P = 0.43). Conclusions: DKA risk associated with CSII in type 1 diabetes has declined substantially since the 1980s such that the remaining risk in the past decade appears to be of low magnitude.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results